Literature DB >> 29590538

STAT3 Gain of Function: A New Kid on the Block in Interstitial Lung Diseases.

Alexandre Fabre1,2, Sarah Marchal3, Lisa Renee Forbes4, Tiphanie Phillips Vogel4, Vincent Barlogis5, Valérie Triolo3, Pierre-Simon Rohrlich6,7, Etienne Bérard8,7, Diane Frankel9,2, Damien Ambrosetti10, Christine Soler6, Marie Hoflack11, Marie Baque12, Emmanuelle Bosdure13, Mélisande Baravalle13, Ania Carsin13, Jean-Christophe Dubus13,2, Lisa Giovannini-Chami3,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29590538     DOI： 10.1164/rccm.201707-1500IM

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  6 in total

1.  The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia.

Authors:  Arun Pradhan; Andrew Dunn; Vladimir Ustiyan; Craig Bolte; Guolun Wang; Jeffrey A Whitsett; Yufang Zhang; Alexey Porollo; Yueh-Chiang Hu; Rui Xiao; Przemyslaw Szafranski; Donglu Shi; Pawel Stankiewicz; Tanya V Kalin; Vladimir V Kalinichenko
Journal:  Am J Respir Crit Care Med       Date:  2019-10-15       Impact factor: 21.405

2.  A Novel STAT3 Gain-of-Function Mutation in Fatal Infancy-Onset Interstitial Lung Disease.

Authors:  Mengyue Deng; Yue Li; Yulu Li; Xiaolan Mao; Han Ke; Weiling Liang; Xiaoguang Lei; Yu-Lung Lau; Huawei Mao
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

3.  [Immune dysregulation syndrome caused by STAT3 gene mutation: a complicated case study].

Authors:  An-Qi Yao; Ke-Ke Chen; Xiang-Ling He; Xin Tian
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2021-04

4.  Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age.

Authors:  Xiaolei Tang; Huimin Li; Hui Liu; Hui Xu; Haiming Yang; Jinrong Liu; Shunying Zhao
Journal:  Orphanet J Rare Dis       Date:  2020-01-22       Impact factor: 4.123

5.  Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation.

Authors:  Wenjie Wang; Luyao Liu; Xiaoying Hui; Ying Wang; Wenjing Ying; Qinhua Zhou; Jia Hou; Mi Yang; Bijun Sun; Jinqiao Sun; Xiaochuan Wang
Journal:  BMC Immunol       Date:  2021-03-17       Impact factor: 3.615

Review 6.  Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype.

Authors:  Laura Faletti; Stephan Ehl; Maximilian Heeg
Journal:  Biomed J       Date:  2021-03-20       Impact factor: 4.910
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.